Median Technologies (ALMDT) announced today that the Company will be participating in the 2022 ESMO (European Society for Medical Oncology) Congress, to be held in Paris, France, September 9-13 (venue: Paris Expo Porte de Versailles).
Read moreBest ever quarterly revenues at €7 million, +43% vs YAGO – Order backlog on June 30th 2022 at €60 million, +14.3% vs YAGO, and Cash Position of €28.2 million (€39 million on Dec. 31st, 2021), despite adverse conditions caused by the lockdown in China
Read moreMedian Technologies will be participating in the 2022 European Congress of Radiology (ECR), to be held in Vienna, Austria, July 13-17. The Company will give an industry presentation and a scientific paper presentation. Median’s team will be available at booth #AI-29, Expo X1, AI-area to discuss the presentations and present the latest developments on iBiopsy® LCS CADe/CADx SaMD from July 13 to 17, 9:00 am-5:00 pm.
Read moreMedian Technologies (ALMDT) announced today that it will be presenting an abstract at the 2022 ASCO Annual Meeting, June 3-7, McCormick Place, Chicago, IL, USA (exhibition dates: June 4-6).
Read moreTo download this content please complete the form below
[contact-form-7 id="5108" title="Download file form"]